ReEmerge is innovating a new way to approach chronic cognitive impairment. Developed under an exclusive licensing agreement with Cornell University, the company's novel Cognitive Network Restoration Therapy (CNRT) precisely targets neural networks disrupted by brain injury that drive underactive but viable neural circuits. By restoring function across these existing but underperforming networks, CNRT aims to reverse cognitive deficits and restore agency and personhood.

Key Contact

Funding Events

Date	Amount	Type	Investors	Valuation
09/16/26	$37,000,000	Series A	415 Capital Dendrion Ventures IAG Capital Partners Oxford Science Enterprises Sante Ventures The Vertical Group US Venture Partners	undisclosed